Warburg Pincus Capital Corporation I-B Appoints Anne Walker as Director and to Serve on the Audit Committee and the Nominating Committee

On August 25, 2021, Warburg Pincus Capital Corporation I-B (the Company") announced the appointment of Anne Walker as a new director of the Company. Ms. Walker has been appointed to serve on the audit committee and the nominating committee of the Company, with such appointment effective upon her becoming a director of the Company. Ms. Walker serves as the Chief Financial Officer of Repertoire Immune Medicines and has held this position since June 2021. Ms. Walker also served as the Bank of America New York City President, and served on the Management Committee.